NEW DELHI: With the aim to reduce dependence on China for import of chemicals, the government is planning a production linked incentive scheme to boost local manufacturing of some of the key chemicals used in pharmaceuticals, insecticides and in other…
OPKO Health evaluates Rayaldee to treat Covid-19 patients
Biopharmaceutical company OPKO Health has launched a Phase II clinical trial to assess Rayaldee as a potential treatment for mild to moderate Covid-19. The drug is an extended-release oral formulation of calcifediol, a prohormone of calcitriol, the active form of…
Lilly reports Covid-19 antibody reduced rate of hospitalisation
Eli Lilly has reported positive proof-of-concept results from the BLAZE-1 clinical trial, which assessed SARS-CoV-2 neutralising antibody candidate LY-CoV555, to treat symptomatic Covid-19 in outpatients. An interim analysis found that the drug candidate decreased rate of hospitalisation. The study involved…
Vaxart secures FDA clearance to trial Covid-19 vaccine candidate
Biotechnology firm Vaxart has received clearance from the US Food and Drug Administration (FDA) to conduct a Phase I clinical trial of its Covid-19 vaccine candidate. The company is developing an oral vaccine to prevent Covid-19. Based on the company’s…
Imperial College team to assess inhaled Covid-19 vaccines
Imperial College London is set to conduct small clinical trials of inhaled versions of Covid-19 vaccines developed by researchers and the University of Oxford. The trials, funded by UKRI-NIHR, will test the safety and efficacy of giving the vaccines as…
AstraZeneca CEO Says COVID-19 Vaccine Trial Pause is the Second Since July
In a private call with investors from J.P. Morgan late Wednesday, AstraZeneca Chief Executive Officer Pascal Soriot confirmed that a woman injected with the company’s experimental COVID-19 vaccine candidate developed a serious spinal inflammatory disorder called transverse myelitis. The trial…
DCGI issues notice to HUL over misleading covid fighting hand sanitiser advertisement
The advertising campaign and packaging of the HUL-owned hygiene product, claiming an immunity boosting effect, are misleading and false as a topical application product. NEW DELHI : The Drug Controller General of India (DCGI) V G Somani has issued a…
DCGI sends notice to Serum Institute for not informing Oxford Covid vaccine trial was halted in UK
The Drug Controller General of India has issued a show-cause notice to Serum Institute of India for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford Covid vaccine candidate in other countries. The Drug Controller…
Russia Approves COVID-19 Vaccine Ahead of Phase III Studies
he government of Russia has approved a vaccine for COVID-19, marking the first preventative treatment for the novel coronavirus. Despite the approval announcement, there is wide skepticism over how effective the Russian vaccine could be due to its early approval.…
The Possibility of Simultaneous COVID-19 and Flu Infections Poses a Double-Threat
As we head into cold and flu season, the question arises: Can you get COVID-19 and the flu at the same time? The short answer is: maybe. There have been some cases reported around the world of people who tested…
